Carrier-free nanoprodrug for p53-mutated tumor therapy via concurrent delivery of zinc-manganese dual ions and ROS

Human cancers typically express a high level of tumor-promoting mutant p53 protein (Mutp53) with a minimal level of tumor-suppressing wild-type p53 protein (WTp53). In this regard, inducing Mutp53 degradation while activating WTp53 is a viable strategy for precise anti-tumor therapy. Herein, a new c...

Full description

Saved in:
Bibliographic Details
Published inBioactive materials Vol. 20; pp. 404 - 417
Main Authors Wang, Jinping, Qu, Chang, Shao, Xinyue, Song, Guoqiang, Sun, Jingyu, Shi, Donghong, Jia, Ran, An, Hailong, Wang, Hongjun
Format Journal Article
LanguageEnglish
Published China Elsevier B.V 01.02.2023
KeAi Publishing
KeAi Communications Co., Ltd
Subjects
Online AccessGet full text

Cover

Loading…